Garth W Strohbehn

20PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Sport and exercise nutritionPowder and particle technologyCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis.

|Jun 04, 2026
Polygenic risk scores for prediction of immune checkpoint inhibitor thyroid toxicity in diverse populations.

|Dec 15, 2025
Low-Carbohydrate Nutrition Counseling With Continuous Glucose Monitoring to Improve Metabolic Health Among Veterans With Type 2 Diabetes: Pilot Quality Improvement Initiative Study.

Cassie D Turner, Kishor Patel, Katherine Freeman

|Feb 06, 2025
Missed Opportunity for Sotorasib Dose Optimization.

Garth W Strohbehn, Jill Feldman, Sanjay Popat

|Jan 05, 2024
'Contribution of component' and the perioperative immune-checkpoint inhibitor precedent.

Garth W Strohbehn, Bishal Gyawali

|Dec 27, 2023
Optimizing the doses of cancer drugs after usual dose finding.

Garth W Strohbehn, Walter M Stadler, Philip S Boonstra

Pageof 4

Frequent Collaborators

4 joint publications

Mark J Ratain

2 joint publications

Alec J Kacew

2 joint publications

Alex K Bryant

2 joint publications

Po-Hung Hsieh